Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.
about
The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseImpaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's diseaseStress, exercise, and Alzheimer's disease: a neurovascular pathway.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureRole of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's diseaseNeurobiology of vascular dementia.Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet.Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal ModelsActivation of PPARδ prevents endothelial dysfunction induced by overexpression of amyloid-β precursor protein.Oxidative stress and β-amyloid protein in Alzheimer's disease.Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research.Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets.
P2860
Q26853347-CB1D4384-8852-4200-95E1-83BF187BC1BCQ28082612-13E2800E-D496-407B-8344-E290A7C779D2Q34981226-062903D3-8606-4389-AF3B-40CDDD3A5B59Q35127516-9A983003-9580-40C3-A2EC-93976F510AF8Q35141182-5C62A356-DF33-4E43-BB3B-D8AC043C43C0Q35176496-43433E53-816F-4A99-827C-C80FDF6B0156Q35866844-FC0D3EB3-C117-4F3E-BA47-392D09D8887EQ36366126-E46792BC-36C4-468D-81BA-292456EC6F05Q36404963-EDA4A381-FB63-4971-8033-D5C6D5032F45Q37928994-10FBCC7F-80CA-4E7F-9EDE-37CD2406BCB5Q38388693-67B4BA18-54C0-4D72-A4DA-DA57AE6F5AEAQ39032252-64B3BADE-190E-4974-9667-A1C81B593A20Q39428686-F4A8CCD0-56A5-4A05-BBEB-FA920DBD3790Q42933669-D3906284-C240-4A5B-B7D3-F1D40F3D25CCQ47855094-945463D8-71EC-432D-92B7-F5B2FB4F2265Q50317765-F2B76DAB-8B7D-4213-B3C9-90EFC824B82F
P2860
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Increased atherosclerosis and ...... h apolipoprotein E deficiency.
@en
Increased atherosclerosis and ...... h apolipoprotein E deficiency.
@nl
type
label
Increased atherosclerosis and ...... h apolipoprotein E deficiency.
@en
Increased atherosclerosis and ...... h apolipoprotein E deficiency.
@nl
prefLabel
Increased atherosclerosis and ...... h apolipoprotein E deficiency.
@en
Increased atherosclerosis and ...... h apolipoprotein E deficiency.
@nl
P2093
P50
P1433
P1476
Increased atherosclerosis and ...... th apolipoprotein E deficiency
@en
P2093
P356
10.1016/J.ATHEROSCLEROSIS.2009.10.040
P50
P577
2009-11-10T00:00:00Z